Viral load is strongly associated with length of stay in adults hospitalised with viral acute respiratory illness

Journal of Infection

Volumn 73, Issue 6, 2016, Pages 598-606

  Clark, Tristan W ^a,b,c   Ewings, Sean ^a   Medina, Marie jo ^c   Batham, Sally ^c   Curran, Martin D ^d   Parmar, Surendra ^d   Nicholson, Karl G ^c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b Southampton NIHR Respiratory Biomedical Research Unit   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Acute respiratory illness; Adults; Hospitalisation; Length of stay; Respiratory viruses; Viral load

Indexed keywords

ADENOVIRIDAE; ADULT; AGE; ARTICLE; BACTERIAL INFECTION; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORONAVIRIDAE; ENTEROVIRUS; FEMALE; HOSPITALIZATION; HUMAN; INFLUENZA A VIRUS; INFLUENZA B VIRUS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METAPNEUMOVIRUS; MIDDLE AGED; MIXED INFECTION; NONHUMAN; PARAMYXOVIRINAE; PREDICTIVE VALUE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; RHINOVIRUS; VIRAL RESPIRATORY TRACT INFECTION; VIRUS LOAD; ACUTE DISEASE; AGED; CLINICAL TRIAL; GENETICS; INFLUENZA; ISOLATION AND PURIFICATION; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTIONS; VERY ELDERLY; VIROLOGY; VIRUS; VIRUS INFECTION;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; COINFECTION; FEMALE; HUMANS; INFLUENZA, HUMAN; LENGTH OF STAY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTIONS; VIRAL LOAD; VIRUS DISEASES; VIRUSES;

EID: 84994761952     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2016.09.001     Document Type: Article

References (35)

1. 1 World Health Organisation fact sheet 310; Top 10 causes of death 2012. Available at: http://www.who.int/mediacentre/factsheets/fs310/en/. [accessed 24.02.15].
2. 2 Jain, S., Williams, D.J., Arnold, S.R., Ampofo, K., Bramley, A.M., Reed, C., et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med 372 (2015), 835–845.
3. 3 D'Acremont, V., Kilowoko, M., Kyungu, E., Philipina, S., Sangu, W., Kahama-Maro, J., et al. Beyond malaria – causes of fever in outpatient Tanzanian children. N Engl J Med 370 (2014), 809–817.
4. 4 Clark, T.W., Medina, M.J., Batham, S., Curran, M.D., Parmar, S., Nicholson, K.G., Adults hospitalised with acute respiratory illness rarely have detectable bacteria in the absence of COPD or pneumonia; viral infection predominates in a large prospective UK sample. J Infect 69 (2014), 507–515.
5. 5 Jain, S., Self, W.H., Wunderink, R.G., Fakhran, S., Balk, R., Bramley, A.M., et al. Community-acquired pneumonia requiring hospitalization among U.S. Adults. N Engl J Med 373 (2015), 415–427.
6. 6 Self, W.H., Williams, D.J., Zhu, Y., Ampofo, K., Pavia, A.T., Chappell, J.D., et al. Respiratory viral detection in children and adults: comparing asymptomatic controls and patients with community-acquired pneumonia. J Infect Dis 213 (2015), 584–591.
7. 7 Byington, C.L., Ampofo, K., Stockmann, C., Adler, F.R., Herbener, A., Miller, T., et al. Community surveillance of respiratory viruses among families in the Utah better identification of germs-longitudinal viral epidemiology (BIG-LoVE) study. Clin Infect Dis 61 (2015), 1217–1224.
8. 8 Shi, T., McLean, K., Campbell, H., Nair, H., Aetiological role of common respiratory viruses in acute lower respiratory infections in children under five years: a systematic review and meta-analysis. J Glob Health, 5, 2015, 010408.
9. 9 Hospital Episode Statistics, Admitted Patient Care – England, 2014–15 [NS], Health and Social Care Information Centre. Available at: http://www.hscic.gov.uk/catalogue/PUB20104. [accessed 24.02.16].
10. 10 Falsey, A.R., Becker, K.L., Swinburne, A.J., Nylen, E.S., Formica, M.A., Hennessey, P.A., et al. Bacterial complications of respiratory tract viral illness: a comprehensive evaluation. J Infect Dis 208 (2013), 432–441.
11. 11 Fritz, R.S., Hayden, F.G., Calfee, D.P., Cass, L.M., Peng, A.W., Alvord, W.G., et al. Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J Infect Dis 180 (1999), 586–593.
12. 12 Hayden, F.G., Fritz, R., Lobo, M.C., Alvord, W., Strober, W., Straus, S.E., Local and systemic cytokine responses during experimental human influenza A virus infection: relation to symptom formation and host defense. J Clin Invest 101 (1998), 643–649.
13. 13 Carrat, F., Vergu, E., Ferguson, N.M., Lemaitre, M., Cauchemez, S., Leach, S., et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 167 (2008), 775–785.
14. 14 Lee, N., Chan, P.K., Hui, D.S., Rainer, T.H., Wong, E., Choi, K.W., et al. Viral loads and duration of shedding in adult patients hospitalized with influenza. J Infect Dis 200 (2009), 492–500.
15. 15 Lee, N., Chan, P.K., Choi, K.W., Lui, G., Wong, B., Cockram, C.S., et al. Factors associated with early hospital discharge of adult influenza patients. Antivir Ther 12 (2007), 501–508.
16. 16 de Jong, M.D., Simmons, C.P., Thanh, T.T., Hien, V.M., Smith, G.J., Chau, T.N., et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12 (2006), 1203–1207.
17. 17 Ison, M.G., de Jong, M.D., Gilligan, K.J., Higgs, E.S., Pavia, A.T., Pierson, J., et al. End points for testing influenza antiviral treatments for patients at high risk of severe and life-threatening disease. End points for testing influenza antiviral treatments for patients at high risk of severe and life-threatening disease. J Infect Dis 201 (2010), 1654–1662.
18. 18 DeVincenzo, J.P., Wilkinson, T., Vaishnaw, A., Cehelsky, J., Meyers, R., Nochur, S., et al. Viral load drives disease in humans experimentally infected with respiratory syncytial virus. Am J Respir Crit Care Med 182 (2010), 1305–1314.
19. 19 Walsh, E.E., Peterson, D.R., Kalkanoglu, A.E., Lee, F.E., Falsey, A.R., Viral shedding and immune responses to respiratory syncytial virus infection in older adults. J Infect Dis 207 (2013), 1424–1432.
20. 20 Duncan, C.B., Walsh, E.E., Peterson, D.R., Lee, F.E., Falsey, A.R., Risk factors for respiratory failure associated with respiratory syncytial virus infection in adults. J Infect Dis 200:8 (2009), 1242–1246.
21. 21 Lee, N., Chan, M.C., Lui, G.C., Li, R., Wong, R.Y., Yung, I.M., et al. High viral load and respiratory failure in adults hospitalized for respiratory syncytial virus infections. J Infect Dis 212 (2015), 1237–1240.
22. 22 Mallia, P., Message, S.D., Gielen, V., Contoli, M., Gray, K., Kebadze, T., et al. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 183 (2011), 734–742.
23. 23 Zhu, J., Message, S.D., Qiu, Y., Mallia, P., Kebadze, T., Contoli, M., et al. Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma. Chest 145 (2014), 1219–1229.
24. 24 Granados, A., Goodall, E.C., Luinstra, K., Smieja, M., Mahony, J., Comparison of asymptomatic and symptomatic rhinovirus infections in university students: incidence, species diversity, and viral load. Diagn Microbiol Infect Dis 82 (2015), 292–296.
25. 25 Muller, M.P., McGeer, A.J., Hassan, K., Marshall, J., Christian, M., Toronto Invasive Bacterial Disease Network. Evaluation of pneumonia severity and acute physiology scores to predict ICU admission and mortality in patients hospitalized for influenza. PLoS One, 5, 2010, e9563.
26. 26 Nicholson, K.G., Abrams, K.R., Batham, S., Medina, M.J., Warren, F.C., Barer, M., et al. Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year-olds. Health Technol Assess, 18, 2014 1–274, vii–viii.
27. 27 Bramer, G.R., International statistical classification of diseases and related health problems. Tenth revision. World Health Stat Q 41 (1988), 32–36.
28. 28 Ginzinger, D.G., Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 30 (2002), 503–512.
29. 29 Lee, N., Choi, K.W., Chan, P.K., Hui, D.S., Lui, G.C., Wong, B.C., et al. Outcomes of adults hospitalised with severe influenza. Thorax 65:6 (2010), 510–515.
30. 30 Muthuri, S.G., Venkatesan, S., Myles, P.R., Leonardi-Bee, J., Al Khuwaitir, T.S., Al Mamun, A., et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2 (2014), 395–404.
31. 31 Yu, L., Wang, Z., Chen, Y., Ding, W., Jia, H., Chan, J.F., et al. Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus. Clin Infect Dis 57 (2013), 1449–1457.
32. 32 Spengler, J.R., McElroy, A.K., Harmon, J.R., Ströher, U., Nichol, S.T., Spiropoulou, C.F., Relationship between Ebola virus real-time quantitative polymerase chain reaction-based threshold cycle value and virus isolation from human plasma. J Infect Dis 212:Suppl. 2 (2015), S346–S349.
33. 33 Yan, T., Mu, J., Qin, E., Wang, Y., Liu, L., Wu, D., et al. Clinical characteristics of 154 patients suspected of having Ebola virus disease in the Ebola holding center of Jui Government Hospital in Sierra Leone during the 2014 Ebola outbreak. Eur J Clin Microbiol Infect Dis 34 (2015), 2089–2095.
34. 34 Jeong, J.H., Kim, K.H., Jeong, S.H., Park, J.W., Lee, S.M., Seo, Y.H., Comparison of sputum and nasopharyngeal swabs for detection of respiratory viruses. J Med Virol 86 (2014), 2122–2127.
35. 35 Falsey, A.R., Formica, M.A., Walsh, E.E., Yield of sputum for viral detection by reverse transcriptase PCR in adults hospitalized with respiratory illness. J Clin Microbiol 50 (2012), 21–24.